+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Postpartum Hemorrhage (PPH) Treatment Devices - Global Strategic Business Report

  • PDF Icon

    Report

  • 207 Pages
  • December 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5141135
The global market for Postpartum Hemorrhage (PPH) Treatment Devices is estimated at US$789.3 Million in 2023 and is projected to reach US$1.1 Billion by 2030, growing at a CAGR of 4.6% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

The growth in the PPH treatment devices market is driven by several factors, including rising global incidence of PPH and the growing awareness about maternal health. Rising complications concerning pregnancy, namely large-sized babies, multiple pregnancies, and inverted uterus are also fueling market growth. Further, increase in other risk factors of PPH, like traumatic uterine and uterine atony, an increase in pregnant women with anemia conditions, and rising awareness concerning PPH risks boost the market growth of postpartum hemorrhage devices. The expanding healthcare infrastructure, especially in emerging economies, has facilitated greater access to these advanced treatment options.

Moreover, government initiatives and funding aimed at reducing maternal mortality rates have bolstered market growth. The demand for minimally invasive and easy-to-use devices that can be employed in a variety of healthcare settings, from tertiary care hospitals to rural clinics, has also spurred innovation in this field. These factors collectively ensure the robust expansion of the market, addressing a critical need in maternal healthcare.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Uterine Balloon Tamponade segment, which is expected to reach US$505.9 Million by 2030 with a CAGR of a 4.3%. The Non-Pneumatic Anti-Shock Garment (NASG) segment is also set to grow at 4.6% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $278.6 Million in 2023, and China, forecasted to grow at an impressive 6.2% CAGR to reach $146.8 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Postpartum Hemorrhage (PPH) Treatment Devices Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Postpartum Hemorrhage (PPH) Treatment Devices Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Postpartum Hemorrhage (PPH) Treatment Devices Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as 3RD Stone Design, Inc., Cook Medical LLC, CooperSurgical, Inc., and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 26 Featured):

  • 3RD Stone Design, Inc.
  • Cook Medical LLC
  • CooperSurgical, Inc.
  • Laborie Medical Technologies Corporation
  • Organon & Co.
  • Revmedx Inc.
  • Sinapi Biomedical
  • Teleflex Incorporated
  • Utah Medical Products, Inc.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Postpartum Haemorrhage - The Leading Cause of Maternal Death Globally
  • PPH: Management using PPH Treatment Devices
  • Global Postpartum Haemorrhage (PPH) Treatment Devices Market by Geographic Region: Annual Sales in Million Units for the Years 2023 through 2030
  • Global Postpartum Haemorrhage (PPH) Treatment Devices Market by Product Segment: Annual Sales in Thousand Units for the Years 2022 through 2030
  • Economic Frontiers: Trends, Trials & Transformations
  • In a World Torn by Geopolitical Instability & War, Steadfastness of Global GDP Becomes Increasingly Unpredictable Given the Many Direct and Indirect Economic Repercussions: World Economic Growth Projections (Real Gross Domestic Product (GDP), Annual % Change) for the Years 2022 Through 2025
  • All Eyes on Global Inflation, the Main Risk Factor in Global Markets: Global Headline Inflation Rates (In %) for the Years 2019 through 2025
  • With Oil Prices Influencing the Rate of inflation, it Remains the Most Watched Commodity in Global Markets: Global Average Annual Brent Crude Oil Price (In US$ Per Barrel) for Years 2019 through 2025
  • Competitive Landscape
  • Postpartum Hemorrhage (PPH) Treatment Devices - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Global Market Prospects and Outlook
  • Global Postpartum Hemorrhage Devices Market Sets Eyes on Pulsating Growth Ahead
  • Uterine Balloon Tamponades Lead the Global PPH Treatment Devices Market
  • US and Europe Account for Major Share of the Market
  • Developing and Developed Countries Investing More in Healthcare Industry
  • Restraining Factors for Market Growth
  • Recent Market Activity
  • Influencer/Product/Technology Insights
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Robust Scope for Device Innovations to Shoulder Burden of Mortality Reduction Goals
  • PPH Device R&D Pipeline: Breakdown of PPH Devices by Development Status
  • Current PPH Devices Ecosystem by Archetype & Clinical Use Status
  • Existing & Promising Postpartum Hemorrhage Devices
  • Balloons Command while New Options Emerge
  • Uterine balloon Tamponade PPH Devices by Archetype & Clinical Use Status
  • Widespread Use of Repurposed & Improvised PPH Devices
  • The Way Forward
  • Novel Techniques for Accurate, Timely Detection & Efficient Management of PPH
  • Timely Hemorrhage Detection
  • Fixed-Ratio Transfusion
  • Viscoelastic Hemostatic Assays
  • Approaches to Reduce Disparate Outcomes
  • Obstetricians Develop Novel Intrauterine PPH Device to Control Postpartum Bleeding
  • Increase in Birth Rate Offers Opportunities for Postpartum Hemorrhage Market
  • Global New Births (in Millions) per Annum by Geographic Region
  • Birth Statistics Across the World
  • Rise in Pregnancy Complications Drives Market Growth
  • Prevalence of Anaemia in Pregnant Women Bolsters Demand
  • The Millennials Reaching Child-Bearing Age Drive Healthy Market Growth
  • TABLE 3: Global Millennial Population by Region (2023): Percentage Breakdown of Number of Millennials for North America, Europe, China & Japan, Latin America and Rest of World
  • Millennial Population as a Percentage (%) of Total Population in Developing Countries: 2023
  • Rising Working Women Population Increases the Risk of PPH
  • Top 10 Countries Worldwide with the Highest Proportion of Working Women in the Nation’s Women Population
  • Rising Obesity Incidence Spurs the Demand for PPH Treatment Devices
  • Obesity Prevalence Rate (%) in Select Countries for the Years 2023 and 2030P
  • Non-Pneumatic Anti-Shock Garment Witnesses Increased Demand
  • Leading Players and Market Share
  • Global Non-Pneumatic Anti-Shock Garment (NASG) Market (2023): Market Share of Major Players
  • Reduction in Maternal Mortality Rates due to Obstetric Haemorrhage from the Use of NASG in Select Countries
  • Supply
  • Challenges and Issues
  • Uterotonics: The Lifeblood of the Bundle Approach to Manage Postpartum Hemorrhage
  • More Focus on Uterine Atony & Uterotonics
  • Uterotonics Move Forward with New Advances to Prevent Postpartum Hemorrhage
  • Device Innovations to Control PPH to Drive Market Growth
  • PATH and Sinapi Biomedical Introduce Ellavi for Combating Postpartum Haemorrhage
  • PPH Butterfly
  • Intrauterine Vacuum Device Plays a Crucial Role in Controlling Postpartum Hemorrhage Safely and Quickly
  • Tools to Detect and Treat Postpartum Hemorrhage Minimize Maternal Deaths
  • New Wearable Optical Device for Timely Detection of Postpartum Hemorrhage
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Postpartum Hemorrhage (PPH) Treatment Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 4: World 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Uterine Balloon Tamponade by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Uterine Balloon Tamponade by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 7: World 16-Year Perspective for Uterine Balloon Tamponade by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Non-Pneumatic Anti-Shock Garment (NASG) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Non-Pneumatic Anti-Shock Garment (NASG) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 10: World 16-Year Perspective for Non-Pneumatic Anti-Shock Garment (NASG) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Uniject Prefilled Injection System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Uniject Prefilled Injection System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 13: World 16-Year Perspective for Uniject Prefilled Injection System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Postpartum Hemorrhage (PPH) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 14: USA Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 15: USA Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 16: USA 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
CANADA
  • TABLE 17: Canada Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 18: Canada Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 19: Canada 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
JAPAN
  • Postpartum Hemorrhage (PPH) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 20: Japan Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 21: Japan Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 22: Japan 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
CHINA
  • Postpartum Hemorrhage (PPH) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 23: China Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 24: China Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 25: China 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
EUROPE
  • Postpartum Hemorrhage (PPH) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 26: Europe Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 27: Europe Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 28: Europe 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 29: Europe Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 30: Europe Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 31: Europe 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
FRANCE
  • Postpartum Hemorrhage (PPH) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 32: France Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 33: France Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 34: France 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
GERMANY
  • Postpartum Hemorrhage (PPH) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 35: Germany Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 36: Germany Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 37: Germany 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
ITALY
  • TABLE 38: Italy Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 39: Italy Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 40: Italy 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Postpartum Hemorrhage (PPH) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 41: UK Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 42: UK Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 43: UK 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
SPAIN
  • TABLE 44: Spain Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 45: Spain Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 46: Spain 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
RUSSIA
  • TABLE 47: Russia Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 48: Russia Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 49: Russia 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
REST OF EUROPE
  • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 51: Rest of Europe Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 52: Rest of Europe 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Postpartum Hemorrhage (PPH) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 54: Asia-Pacific Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 55: Asia-Pacific 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 57: Asia-Pacific Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 58: Asia-Pacific 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
AUSTRALIA
  • Postpartum Hemorrhage (PPH) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
INDIA
  • Postpartum Hemorrhage (PPH) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Postpartum Hemorrhage (PPH) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
BRAZILREST OF LATIN AMERICA
MIDDLE EAST
  • Postpartum Hemorrhage (PPH) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
AFRICA
  • Postpartum Hemorrhage (PPH) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
IV. COMPETITION

Companies Mentioned

  • 3RD Stone Design, Inc.
  • Cook Medical LLC
  • CooperSurgical, Inc.
  • Laborie Medical Technologies Corporation
  • Organon & Co.
  • Revmedx Inc.
  • Sinapi Biomedical
  • Teleflex Incorporated
  • Utah Medical Products, Inc.

Table Information